首页 > 市场调查报告书 > 製药

疼痛

全球控释大麻丸市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

市场调查报告书

商品编码

1421093

全球控释大麻丸市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Controlled Release Cannabis Pills Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年01月01日 | 出版商:

Value Market Research | 英文 134 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球控释大麻丸市场需求预计将从 2023 年的 112.2 亿美元达到 2032 年近 152.3 亿美元的市场规模，2024 - 2032 年研究期间CAGR为 3.45%。

控释大麻丸通常是指含有大麻素（大麻中发现的活性化合物）的口服药物製剂，旨在提供药物在体内的受控和持续释放。这些製剂旨在长期调节大麻素的释放，与传统的速释製剂相比，提供更渐进和更持久的治疗效果。

市场动态

控释大麻丸市场是由医用大麻和製药创新交叉因素所驱动的。大麻素的治疗潜力，特别是在治疗慢性疾病方面，刺激了对提供稳定和延长释放的控释製剂的需求。患者的便利性和依从性的提高是重要的驱动因素，因为控释药物提供了更方便的给药选择。标准化配方符合监管要求，提高了医药市场对大麻药物的接受度。剂量的精确性允许客製化治疗计划，优化治疗结果。药物传递技术的进步有助于复杂製剂的开发。随着医用大麻市场的不断扩大和持续的研究投资，控释大麻药丸代表了药物中不断增长的部分，以满足患者对口服给药的偏好。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球控释大麻药丸市场的每个细分市场进行了包容性评估。控释大麻药丸产业的成长和趋势为本研究提供了整体方法。

市场区隔

控释大麻药丸市场报告的这一部分提供了国家和区域一级细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

高 THC 胶囊
THC/CBD 平衡胶囊
高 CBD 胶囊

按最终用途

医院药房
零售药局
药局
网上销售

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的控释大麻丸市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。控释大麻丸市场的主要参与者包括 Cannabics Pharmaceuticals 、 Wana Edibles 、 Depomed 、 Corium International Inc . 、 Collegium Pharmaceutical 、 GlaxoSmithKline 。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：大麻控释丸公司的竞争格局

控释大麻丸市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Cannabics Pharmaceuticals

公司简介
公司收入
产品
最近的发展

Wana Edibles

公司简介
公司收入
产品
最近的发展

Depomed

公司简介
公司收入
产品
最近的发展

Corium International Inc.

公司简介
公司收入
产品
最近的发展

Collegium Pharmaceutical

公司简介
公司收入
产品
最近的发展

GlaxoSmithKline

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112113494

The global demand for Controlled Release Cannabis Pills Market is presumed to reach the market size of nearly USD 15.23 Billion by 2032 from USD 11.22 Billion in 2023 with a CAGR of 3.45% under the study period 2024 - 2032.

Controlled Release Cannabis Pills typically refer to oral pharmaceutical formulations containing cannabinoids, the active compounds found in cannabis, that are designed to provide a controlled and sustained release of the drug within the body. These formulations aim to regulate the release of cannabinoids over an extended period, offering a more gradual and prolonged therapeutic effect compared to traditional immediate-release formulations.

MARKET DYNAMICS

The Controlled Release Cannabis Pills market, is driven by factors at the intersection of medical cannabis and pharmaceutical innovations. The therapeutic potential of cannabinoids, especially in managing chronic conditions, fuels demand for controlled-release formulations offering steady and prolonged release. Patient convenience and improved adherence are significant drivers, as controlled-release pills provide a more convenient dosing option. Standardized formulations align with regulatory requirements, enhancing the acceptance of cannabis-based medications in pharmaceutical markets. The precision in dosing allows tailored treatment plans, optimizing therapeutic outcomes. Advances in drug delivery technologies contribute to the development of sophisticated formulations. With the expanding medical cannabis market and ongoing research investments, controlled release cannabis pills represent a growing segment in pharmaceuticals, catering to patient preferences for oral delivery.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of controlled release cannabis pills. The growth and trends of controlled release cannabis pills industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the controlled release cannabis pills market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

High THC Capsule
THC/CBD Balanced Capsules
High CBD Capsules

By End-Use

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Controlled Release Cannabis Pills market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Controlled Release Cannabis Pills market include Cannabics Pharmaceuticals, Wana Edibles, Depomed, Corium International Inc., Collegium Pharmaceutical, GlaxoSmithKline. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CONTROLLED RELEASE CANNABIS PILLS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By End-Use
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CONTROLLED RELEASE CANNABIS PILLS MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 High THC Capsule Historic and Forecast Sales by Regions
5.5 THC/CBD Balanced Capsules Historic and Forecast Sales by Regions
5.6 High CBD Capsules Historic and Forecast Sales by Regions

6 . GLOBAL CONTROLLED RELEASE CANNABIS PILLS MARKET ANALYSIS BY END-USE

6.1 Overview by End-Use
6.2 Historical and Forecast Data
6.3 Analysis by End-Use
6.4 Hospital Pharmacies Historic and Forecast Sales by Regions
6.5 Retail Pharmacies Historic and Forecast Sales by Regions
6.6 Drug Stores Historic and Forecast Sales by Regions
6.7 Online Sales Historic and Forecast Sales by Regions

7 . GLOBAL CONTROLLED RELEASE CANNABIS PILLS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Data Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Data Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Data Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. South East Asia Sales Analysis
- 7.5.10. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Data Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Data Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE CONTROLLED RELEASE CANNABIS PILLS COMPANIES

8.1. Controlled Release Cannabis Pills Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF CONTROLLED RELEASE CANNABIS PILLS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Cannabics Pharmaceuticals
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Wana Edibles
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. Depomed
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. Corium International Inc.
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. Collegium Pharmaceutical
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. GlaxoSmithKline
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments